Blood Group Typing Market Trends

  • Report ID: 4555
  • Published Date: Sep 10, 2025
  • Report Format: PDF, PPT

Blood Group Typing Market Growth Drivers and Challenges:

Growth Drivers

  • Increasing Prenatal Testing to Detect Genetic Disorders of Baby Before Birth - To prevent hemolytic anemia in newborns during pregnancy (HDN), blood typing tests are very important during pregnancy. Hence, the rising demand for prenatal testing during pregnancy is expected to higher the adoption of blood group typing during the forecast period. For instance, 86% of pregnancies generally involved invasive diagnostic testing. As of 2019, in Taiwan trisomy 21 and 18 are found at a rate of 96% and 98%, respectively, compared to 74% and 82% respectively in 2006.

  • Rising Prevalence of Thalassemia Worldwide with Increasing Migrations - An individual with thalassemia has less hemoglobin than the average person due to an inherited blood disorder. Thus, for timely diagnosis of thalassemia and treatment, blood group typing technologies is anticipated to grow considerably over the next few years. It was observed that around the world, approximately 4.5 out of every 10,000 live births are affected by this disease.

  • Growing Need for Blood Transfusion Owing to Rising Surgeries, Injuries, and Illness - For instance, over 4.4 million people need blood transfusions every year in the United States. It is also anticipated that this number is expected to go up in the future.

  • Increasing Road Traffic Accidents as Drunk Driving, Speeding and Distracted Driving Grow - As a result of heavy blood loss during road traffic accidents, there is a surge in the demand for blood transfusions, which is projected to positively impact the blood group typing market. Around 1.3 million people die each year in road traffic accidents globally, according to the World Health Organization.

  • Growth in the Number of Blood Donors with Government Blood Camps Rising Awareness among People - For instance as compared to 2019, new donor registrations in 2020 grew from 23,990 to 36,500, with the greatest growth between weeks 11–20 from 10,880 to 26,620 in United States.

Challenges

  • Lack of Healthcare Infrastructure in Developing Countries - Highly expensive healthcare facilities are not covered by insurance, and some do not have any insurance help. Growing living costs and increasing food prices leave no choice for low-income people but to let go of their healthcare needs.
  • Reduction in Blood Donation Camps During COVID 19
  • Risk of Concern During Blood Transfusion

Base Year

2025

Forecast Period

2026-2035

CAGR

9.2%

Base Year Market Size (2025)

USD 2.3 Billion

Forecast Year Market Size (2035)

USD 5.55 Billion

Regional Scope

  • North America (U.S. and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, South Korea, Malaysia, Australia, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Browse key industry insights with market data tables & charts from the report:

Frequently Asked Questions (FAQ)

In the year 2026, the industry size of blood group typing is estimated at USD 2.49 Billion.

The global blood group typing market size was over USD 2.3 Billion in 2025 and is anticipated to witness a CAGR of around 9.2%, crossing USD 5.55 Billion revenue by 2035.

North America blood group typing market will hold over 42.4% share by 2035, attributed to the increasing need for blood transfusions, favorable reimbursement policies, and rising chronic disease cases in the region.

Key players in the market include Seegene Inc,QuidelOrtho Corporation, Rapid Labs Ltd, BAG Health Care GmbH, Quotient Suisse SA, Bio-Rad Laboratories Inc., Beckman Coulter Inc., Grifols, S.A., Immucor Inc., Novacyt Group.
Inquiry Before Buying Request Free Sample PDF
footer-bottom-logos